To study the frequency of ERK activation in primary liver cancers, p-ERK was analyzed using a tissue microarray (TMA) containing 78 hepatocellular carcinoma specimens by immunochemical analysis. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.